Bioxyne Limited (AU:BXN) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Bioxyne Limited has announced a change in director Anthony Ho’s interests, with the acquisition of 5 million unlisted options approved by shareholders. The options have an exercise price of $0.02 and expire in December 2027. This change aligns with the company’s strategic decisions and reflects shareholder support.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue